Results 251 to 260 of about 38,036,070 (284)

Neurofibromatosis type 1 system-based manifestations and treatments: a review

Neurological Sciences, 2023
Mustafa Saleh, AlFadel Dib, S. Beaini, Charbel G. Saad, Sary Faraj, Youssef El Joueid, Yasmine Kotob, Lara Saoudi, Nancy Emmanuel   +8 more
semanticscholar   +1 more source

Constipation in Children With Neurofibromatosis Type 1

Journal of Pediatric Gastroenterology and Nutrition, 2013
ABSTRACTBackground and Objectives:Neurofibromatosis type 1 (NF1) is a hereditary, heterogenic, and multiorganic disease. The NF1 phenotype shows great variability in expressivity and often includes symptoms from the central and peripheral nervous systems. Bowel symptoms have been reported, but gastrointestinal function in NF1 remains to be described in
Pedersen, Cecilie E; id_orcid 0000-0003-3815-0613, Krogh, Klaus; id_orcid 0000-0001-9168-2403, Siggaard, Charlotte, Joensson, Iben M, Haagerup, Annette   +4 more
openaire   +5 more sources

Neurofibromatosis Type 1

Archives of Neurology, 1993
Recent advances in molecular genetics have enabled researchers to more rapidly identify human disease genes. The identification of these genes by positional cloning has opened the door to a better understanding of such diseases through a more complete appreciation of the molecular biologic processes that underlie them.
D H, Gutmann, F S, Collins
openaire   +2 more sources

Epilepsy surgery in Neurofibromatosis Type 1

Epilepsy Research, 2013
Epilepsy is relatively uncommon in patients with Neurofibromatosis Type 1 (NF1) and seizures are usually well controlled with antiepileptic treatment. However, pharmacoresistance has been reported in patients with NF1 and MRI evidence of malformations of cortical development or glioneuronal tumours.
Barba C, Jacques T, Kahane P, Polster T, Isnard J, Leijten FS, Ozkara C, Tassi L, Giordano F, Castagna M, John A, Oz B, Salon C, Streichenberger N, Cross JH, GUERRINI, RENZO   +15 more
openaire   +4 more sources

Neurofibromatosis Type 1 and Precocious Puberty

Journal of Pediatric Endocrinology and Metabolism, 2000
Since neurofibromatosis type 1 (NF1) is a well known cause of precocious puberty (PP), we reviewed 412 NF1 pediatric patients to evaluate the prevalence of PP, the association with optic pathway tumors (OPT), and other clinical, auxological and hormonal data.
Virdis R., Sigorini M., Laiolo A., Lorenzetti E., Street M. E., Villani A. R., Donadio A., Pisani F., Terzi C., Garavelli L.   +9 more
openaire   +2 more sources

Epidemiology of neurofibromatosis type 1

American Journal of Medical Genetics, 1999
The prevalence of neurofibromatosis type 1 (NF1) is about 1/3,000. There are no known ethnic groups in which NF1 does not occur or is unusually common. The prevalence is somewhat higher in young children than in adults, a difference that probably results at least in part from the early death of some NF1 patients.
openaire   +2 more sources

Neurofibromatosis type 1

Medical and Pediatric Oncology, 1995
Giulio J. D'Angio, Audrey E. Evans, Anna Janss, John F. Hiehle, Anthony T. Yachnis   +4 more
openaire   +2 more sources

Neurofibromatosis Type 1

2003
Margaret E, McLaughlin, Tyler, Jacks
openaire   +2 more sources

Neurofibromatosis type 1 in childhood

The Journal of Pediatrics, 1990
R, Listernick, J, Charrow
openaire   +2 more sources

Vasculopathy in Neurofibromatosis Type 1

Radiology, 2023
Azadehsadat Esfahani, Ayaz Aghayev
openaire   +2 more sources